Sara W. Koblitz

Director at Hyman, Phelps & McNamara, P.C.

Speaker

SARA WEXLER KOBLITZ is a Director at Hyman, Phelps & McNamara, P.C. in Washington D.C. Ms. Koblitz advises FDA-regulated clients on a range of issues with a particular focus on Hatch-Waxman patent and exclusivity, the Orange Book, the Biologics Price Competition and Innovation Act, biosimilars, and the Purple Book. She helps drug manufacturers in various stages of product development and guides clients through the applicable regulatory requirements with respect to applications and submissions, potential exclusivities, promotional issues, and post-marketing requirements. Ms. Koblitz has written and spoken widely on all aspects of Hatch-Waxman and the BPCIA. Ms. Koblitz graduated from Duke University School of Law in 2012 and from the Johns Hopkins University in 2006.